Hormone receptor positive

Hormone receptor positive refers to a type of cancer that is sensitive to hormones. This type of cancer has receptors for certain hormones, such as estrogen and progesterone, which can stimulate the cancer cells to grow. Hormone receptor positive cancers are often treated with hormone therapy.

Overview

Hormone receptor positive cancers are most commonly found in breast cancer and prostate cancer. In breast cancer, the presence of estrogen and progesterone receptors is a key factor in determining treatment options. Similarly, in prostate cancer, the presence of androgen receptors can influence treatment decisions.

Diagnosis

The diagnosis of hormone receptor positive cancer is made through a biopsy, where a sample of the tumor is examined under a microscope. The presence of hormone receptors can be determined through a process called immunohistochemistry.

Treatment

Treatment for hormone receptor positive cancers often involves hormone therapy. This can include drugs that block the production of hormones, such as aromatase inhibitors, or drugs that block the action of hormones, such as tamoxifen.

Prognosis

The prognosis for hormone receptor positive cancers is generally good, as these cancers often respond well to hormone therapy. However, the prognosis can vary depending on other factors, such as the stage of the cancer and the patient's overall health.

See also

• Breast cancer
• Prostate cancer
• Hormone therapy
• Aromatase inhibitors
• Tamoxifen

Hormone receptor positive Resources
Latest articles Most recent articles Ongoing trials	Wikipedia